{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:33:01Z","timestamp":1788496381157,"version":"build-2803163510"},"reference-count":34,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Little is known about body composition changes in patients with acute myeloid leukemia (AML) during and after treatment or their associations with outcomes. Z-scores for body mass index (BMI), weight, and height at diagnosis, their longitudinal changes from diagnosis to 5 years off therapy, and their associations with adverse effects and outcomes were evaluated in 227 pediatric patients with AML enrolled in the AML02 and AML08 trials at St. Jude Children\u2019s Research Hospital between 2002-2017. The median Z-scores for baseline weight, height, and BMI were 0.193, 0.209, and 0.170, respectively, and those for weight and height decreased significantly during therapy to \u22120.038 and \u22120.163, respectively, at off-therapy (P\u2009&amp;lt;\u2009.001 for both). At 5 years off therapy, the Z-scores for weight and BMI had increased significantly to 0.492 (P\u2009=\u2009.003) and 0.911 (P\u2009&amp;lt;\u2009.001), respectively, whereas the height Z-score remained significantly lower at \u22120.066 (P\u2009&amp;lt;\u2009.001) compared with baseline. The height Z-score of transplant recipients decreased further from \u22120.211 at transplant to \u22120.617 12 months later (P\u2009&amp;lt;\u2009.001). Baseline BMI category and Z-score were not associated with outcomes, but higher weight Z-scores were associated with lower incidences of refractory or relapsed disease (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.67-0.99) and higher incidences of death in remission (HR, 1.31; 95% CI, 1.01-1.70). Furthermore, weight Z-score decrease during induction therapy was associated with gastrointestinal, hepatic, and infection toxicities during subsequent therapy and with death in remission (HR, 2.66; 95% CI, 1.11-6.45). Multidisciplinary monitoring for weight changes and short stature is required from diagnosis to the off-therapy period.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006090","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T18:51:36Z","timestamp":1645642296000},"page":"2824-2834","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome"],"prefix":"10.1182","volume":"6","author":[{"given":"Mayuko","family":"Iijima","sequence":"first","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"},{"name":"Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5765-4465","authenticated-orcid":false,"given":"Melanie","family":"Stall","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Panetta","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-9980","authenticated-orcid":false,"given":"Brandon M.","family":"Triplett","sequence":"additional","affiliation":[{"name":"Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-5658","authenticated-orcid":false,"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9956-5647","authenticated-orcid":false,"given":"Raul C.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-3527","authenticated-orcid":false,"given":"Jeffrey E.","family":"Rubnitz","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley B.","family":"Pounds","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"issue":"27","key":"2022050515305805900_B1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative efforts driving progress in pediatric acute myeloid leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J Clin Oncol."},{"issue":"10","key":"2022050515305805900_B2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41375-018-0071-7","article-title":"Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012","volume":"32","author":"Rasche","year":"2018","journal-title":"Leukemia."},{"issue":"16","key":"2022050515305805900_B3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA."},{"issue":"21","key":"2022050515305805900_B4","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1002\/cncr.31736","article-title":"Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia","volume":"124","author":"Browne","year":"2018","journal-title":"Cancer."},{"issue":"13","key":"2022050515305805900_B5","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/cncr.29153","article-title":"Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort","volume":"121","author":"Wilson","year":"2015","journal-title":"Cancer."},{"issue":"6","key":"2022050515305805900_B6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/cncr.31191","article-title":"Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: a focus on sarcopenic obesity","volume":"124","author":"Marriott","year":"2018","journal-title":"Cancer."},{"issue":"2","key":"2022050515305805900_B7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.293.2.203","article-title":"Mortality in overweight and underweight children with acute myeloid leukemia","volume":"293","author":"Lange","year":"2005","journal-title":"JAMA."},{"issue":"23","key":"2022050515305805900_B8","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1002\/cncr.27640","article-title":"Effect of body mass index on the outcome of children with acute myeloid leukemia","volume":"118","author":"Inaba","year":"2012","journal-title":"Cancer."},{"issue":"11","key":"2022050515305805900_B9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3324\/haematol.2016.146175","article-title":"Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004","volume":"101","author":"L\u00f8hmann","year":"2016","journal-title":"Haematologica."},{"issue":"15","key":"2022050515305805900_B10","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1002\/cam4.2554","article-title":"Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia","volume":"8","author":"L\u00f8hmann","year":"2019","journal-title":"Cancer Med."},{"issue":"6","key":"2022050515305805900_B11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","article-title":"Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial","volume":"11","author":"Rubnitz","year":"2010","journal-title":"Lancet Oncol."},{"issue":"23","key":"2022050515305805900_B12","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1200\/JCO.19.00327","article-title":"Clofarabine can replace anthracyclines and etoposide in remission induction therapy for childhood acute myeloid leukemia: the AML08 multicenter, randomized phase III trial","volume":"37","author":"Rubnitz","year":"2019","journal-title":"J Clin Oncol."},{"issue":"13","key":"2022050515305805900_B13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/cncr.28688","article-title":"Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia","volume":"120","author":"Inaba","year":"2014","journal-title":"Cancer."},{"issue":"1","key":"2022050515305805900_B14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version","volume":"109","author":"Ogden","year":"2002","journal-title":"Pediatrics."},{"issue":"7","key":"2022050515305805900_B15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/pbc.24960","article-title":"Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL)","volume":"61","author":"Zhang","year":"2014","journal-title":"Pediatr Blood Cancer."},{"issue":"12","key":"2022050515305805900_B16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3324\/haematol.2016.148908","article-title":"Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study","volume":"101","author":"Saultier","year":"2016","journal-title":"Haematologica."},{"issue":"10112","key":"2022050515305805900_B17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet."},{"issue":"9","key":"2022050515305805900_B18","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/cncr.24209","article-title":"Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"115","author":"Ness","year":"2009","journal-title":"Cancer."},{"issue":"6","key":"2022050515305805900_B19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.pcl.2020.08.002","article-title":"Endocrine health in childhood cancer survivors","volume":"67","author":"van Santen","year":"2020","journal-title":"Pediatr Clin North Am."},{"issue":"2","key":"2022050515305805900_B20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000496354","article-title":"Growth disturbances in childhood cancer survivors","volume":"91","author":"Antal","year":"2019","journal-title":"Horm Res Paediatr."},{"issue":"6","key":"2022050515305805900_B21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MPH.0000000000000555","article-title":"Prevalence and predictors of overweight and obesity among a multiethnic population of pediatric acute lymphoblastic leukemia survivors: a cross-sectional assessment","volume":"38","author":"Brown","year":"2016","journal-title":"J Pediatr Hematol Oncol."},{"issue":"10","key":"2022050515305805900_B22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1200\/JCO.2006.07.8709","article-title":"Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma","volume":"25","author":"Razzouk","year":"2007","journal-title":"J Clin Oncol."},{"issue":"6","key":"2022050515305805900_B23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/pbc.21063","article-title":"Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia","volume":"49","author":"Baillargeon","year":"2007","journal-title":"Pediatr Blood Cancer."},{"issue":"2","key":"2022050515305805900_B24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/pon.4528","article-title":"Factors associated with physical activity among adolescent and young adult survivors of early childhood cancer: a report from the childhood cancer survivor study (CCSS)","volume":"27","author":"Devine","year":"2018","journal-title":"Psychooncology."},{"issue":"10","key":"2022050515305805900_B25","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/cncr.21009","article-title":"Survivors of childhood cancer and their guardians","volume":"103","author":"Demark-Wahnefried","year":"2005","journal-title":"Cancer."},{"issue":"10","key":"2022050515305805900_B26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA."},{"issue":"6","key":"2022050515305805900_B27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/10428194.2017.1365861","article-title":"Acute myeloid leukemia and the infectious diseases consultant","volume":"59","author":"Mulanovich","year":"2018","journal-title":"Leuk Lymphoma."},{"issue":"1","key":"2022050515305805900_B28","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MPH.0b013e31822817a6","article-title":"Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children\u2019s Oncology Group","volume":"34","author":"Sung","year":"2012","journal-title":"J Pediatr Hematol Oncol."},{"issue":"1","key":"2022050515305805900_B29","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/bcj.2015.110","article-title":"Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004","volume":"6","author":"Bochennek","year":"2016","journal-title":"Blood Cancer J."},{"issue":"3","key":"2022050515305805900_B30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cncr.23581","article-title":"Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis","volume":"113","author":"Inaba","year":"2008","journal-title":"Cancer."},{"issue":"3","key":"2022050515305805900_B31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/pbc.20435","article-title":"Standards of nutritional care in pediatric oncology: results from a nationwide survey on the standards of practice in pediatric oncology. A Children\u2019s Oncology Group study","volume":"46","author":"Ladas","year":"2006","journal-title":"Pediatr Blood Cancer."},{"issue":"7","key":"2022050515305805900_B32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/pbc.24272","article-title":"Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions","volume":"59","author":"Co-Reyes","year":"2012","journal-title":"Pediatr Blood Cancer."},{"issue":"6","key":"2022050515305805900_B33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2352-4642(19)30407-9","article-title":"Nutrition during childhood cancer treatment: current understanding and a path for future research","volume":"4","author":"Joffe","year":"2020","journal-title":"Lancet Child Adolesc Health."},{"issue":"2","key":"2022050515305805900_B34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3945\/an.110.000141","article-title":"Important aspects of nutrition in children with cancer","volume":"2","author":"Bauer","year":"2011","journal-title":"Adv Nutr."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/9\/2824\/1895000\/advancesadv2021006090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/9\/2824\/1895000\/advancesadv2021006090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T15:33:13Z","timestamp":1651764793000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/9\/2824\/484112\/Changes-in-body-mass-index-weight-and-height-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006090","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}